CompletedNot Applicable

Interactive Study to Increase Glaucoma Adherence to Treatment

United States312 participantsStarted 2008-08

Plain-language summary

Study participants who receive the I-SIGHT intervention will have higher rates of glaucoma treatment compliance (e.g., medication-taking and refill compliance, return for clinical follow-up) and more positive eye health outcomes at 12-month follow-up than participants who receive the control group intervention.

Who can participate

Age range18 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Receive treatment at the Atlanta VA Medical Center or Grady Eye clinic for their eye condition * Be between the ages of 18-80 * Be Caucasian or African American * Possess a telephone (home telephone or cellular phone) * Speak and understand English * Be diagnosed with open angle glaucoma, be glaucoma suspect, or be ocular hypertensive for at least one year * Be prescribed daily doses of topical treatments for at least one year * Be able to read or have someone who can help the participant with reading written materials that we give to the participant Exclusion Criteria: * Having eye surgery within 3 months of baseline interview and enrollment * Being legally blind (20/200 or worse)

What they're measuring

Data on Prescription Drug Renewals, Appointment Compliance and Medication Taking (e.g. Physician Notes)

Timeframe: Baseline and 12 months

Trial details

NCT IDNCT00794170

SponsorEmory University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2010-06

Results submitted2012-08-15

View on ClinicalTrials.gov More Glaucoma trials